Several members of the UC Davis School of Veterinary Medicine’s Veterinary Institute for Regenerative Cures (VIRC) lectured at the 2025 North American Veterinary Regenerative Medicine Association (NAVRMA) Conference, including keynote addresses. The 3-day conference is a gathering of some of the leading minds in stem cell and other regenerative medicine research in veterinary and human medicine.
Collaborative and translational research is a cornerstone of advancing the science of veterinary medicine at UC Davis. Three scientists at the university are taking regenerative medicine to new heights.
UC Davis’ Veterinary Institute for Regenerative Cures (VIRC) recently attended the North American Veterinary Regenerative Medicine Association Conference at Colorado State University’s C. Wayne Mcllwraith Translational Medical Institute. VIRC’s award-winning presence at the conference included five podium lectures and three research poster presentations.
Life for Miro, a 5-year-old German shepherd, has been what his owner describes as an “emotional roller coaster” over the past two years. Several peaks and valleys have dotted his metaphorical landscape as he has gone from premiere fitness to dealing with injuries and disease. But a clinical trial at the UC Davis veterinary hospital may have put him back on a positive track.
Since 2012, the Veterinary Institute for Regenerative Cures (VIRC) at the UC Davis School of Veterinary Medicine (SVM) has been committed to transforming the SVM into a national leader for veterinary regenerative medicine. VIRC has established laboratory techniques and animal models that have been used to study regenerative therapies for veterinary and human medicine. It has characterized equine, canine and feline stem cells isolated from different tissues with a focus on adult-derived mesenchymal stem cells.
